Age and aging in blood disorders: multiple myeloma

door Zweegman, Sonja, Palumbo, Antonio, Bringhen, Sara, Sonneveld, Pieter
Gepubliceerd in 2014

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

door Engelhardt, Monika, Yong, Kwee, Bringhen, Sara, Wäsch, Ralph
Gepubliceerd in Haematologica (2019)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

door Mattia D’Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Gepubliceerd in 2020-11-01

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

door D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
Gepubliceerd in Int J Mol Sci (2020)

Emerging drugs and combinations to treat multiple myeloma

door Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Gepubliceerd in Oncotarget (2017)

Approach to the Older Adult With Multiple Myeloma

door Mina, Roberto, Bringhen, Sara, Wildes, Tanya M., Zweegman, Sonja, Rosko, Ashley E.
Gepubliceerd in Am Soc Clin Oncol Educ Book (2019)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

door Bonello, Francesca, Grasso, Mariella, D’Agostino, Mattia, Celeghini, Ivana, Castellino, Alessia, Boccadoro, Mario, Bringhen, Sara
Gepubliceerd in Pharmaceuticals (Basel) (2020)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

door Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
Gepubliceerd in J Clin Med (2020)

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

door Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
Gepubliceerd in Cancers (Basel) (2019)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

door M Mateos, X Leleu, E Zamagni, M Delforge, S Bringhen, A Broijl, J de la Rubia, A Shaw, A Brescianini, S Gonzalez-McQuire, S Patel, P Moreau
Gepubliceerd in 2022-04-01

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

door Bringhen, Sara, Voorhees, Peter M., Plesner, Torben, Mellqvist, Ulf‐Henrik, Reeves, Brandi, Sonneveld, Pieter, Byrne, Catriona, Nordström, Eva, Harmenberg, Johan, Obermüller, Jakob, Richardson, Paul G.
Gepubliceerd in Br J Haematol (2021)

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

door Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
Gepubliceerd in J Geriatr Oncol (2020)

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

door Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola
Gepubliceerd in 2014

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

door Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto
Gepubliceerd in Cancers (Basel) (2021)

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

door Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto
Gepubliceerd in Front Cardiovasc Med (2021)

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

door Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul
Gepubliceerd in 2010

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

door Dimopoulos, Meletios, Bringhen, Sara, Anttila, Pekka, Capra, Marcelo, Cavo, Michele, Cole, Craig, Gasparetto, Cristina, Hungria, Vania, Jenner, Matthew, Vorobyev, Vladimir, Ruiz, Eduardo Yanez, Yin, Jian Y., Saleem, Rao, Hellet, Maeva, Macé, Sandrine, Paiva, Bruno, Vij, Ravi
Gepubliceerd in Blood (2021)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

door Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Gepubliceerd in Haematologica (2021)

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

door Facon, Thierry, Niesvizky, Ruben, Mateos, Maria-Victoria, Siegel, David, Rosenbaum, Cara, Bringhen, Sara, Weisel, Katja, Ho, P. Joy, Ludwig, Heinz, Kumar, Shaji, Wang, Kenneth, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Mezzi, Khalid, Goldrick, Amanda, Tekle, Christina, Dimopoulos, Meletios A.
Gepubliceerd in Blood Adv (2020)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-do...

door Mateos, María-Victoria, Bringhen, Sara, Richardson, Paul G., Lahuerta, Juan Jose, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, García-Sanz, Ramón, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesús F., Palumbo, Antonio
Gepubliceerd in 2014